Monday, January 31, 2022

Did You Know? What's New at OWH

What's New at OWH...

Just released: Standardized clinical definition for opioid withdrawal in neonates

HHS in partnership with national experts recently took action to ensure accurate and consistent bedside diagnosis of opioid withdrawal in neonates, or newborn babies. By recommending a standardized clinical definition with accompanying bioethical principles, the goal is to improve the clinical and supportive needs assessment of the mother and her baby and are not meant to prove or imply harm. Improved diagnosis aimed at reducing stigma is the first step to ensuring infants and families with opioid exposure get the care they need. Read more, here: https://go.usa.gov/xtEPX.

HHS Endocrine-Disrupting Chemicals (EDC) Innovator Award Competition

Extended Deadline: March 31, 2022
Do you have an innovative idea to raise awareness about the health effects of endocrine-disrupting chemicals (EDCs)? Apply today for the HHS Office on Women's Health national prize competition! A total of $1.3 million will be awarded for programs that address knowledge gaps in understanding the risks associated with EDCs and provide solutions to reduce EDC exposure risks on Black or African American Women.

For more information, visit: https://go.usa.gov/xtRUW

...and Coming Soon!

Follow @womenshealth in February as we share tips, tools, and resources in support of American Heart Month and National Eating Disorders Awareness Week!

Closing the Evidence to Practice Gap

HHS Racial Equity in Postpartum Care Challenge

New Deadline: February 28, 2022

The Office on Women's Health in partnership with the Centers for Medicare and Medicaid Services (CMS) is seeking innovative ways to improve postpartum care for Black or African American and American Indian or Alaska Native (AI/AN) enrolled in Medicaid or Children's Health Insurance Program (CHIP). The focus: follow-up care for diabetes, postpartum depression and/or postpartum anxiety, hypertension, and substance use disorders (SUD). Total cash prizes: $1.8 million. Join an informational webinar to learn more:

February 9th, 12 pm ET Register: https://bit.ly/3r2GsPi

Words for Wellness

OWH Blog

Check out our latest blogs and learn what actions you can take to improve your health!

National Clinical Care Commission Issues Final Report to Improve Diabetes Prevention and Treatment
Office on Women's Health Awards $4.1 Million to Reduce Maternal Deaths Due to Violence
HHS Press Release: HHS Awards $6.6 Million to Address Increased Need for Title X Family Planning Services
HHS Fact Sheet: Reproductive Healthcare Access Task Force

What's New in Women's Health Research

Are you up to date on your COVID-19 vaccination and booster? Research shows COVID-19 vaccination with a booster shot prevents severe disease and provides protection against infection even during the emergence of the Omicron variant.

Remember: Pregnant people who get COVID-19 are more at risk for severe illness, delivering their babies early, and stillbirth. And a new study suggests COVID-19 vaccination does not reduce chances of conception. Get your COVID-19 vaccination and booster today. Visit vaccines.gov to find a location near you.

Preferences | Unsubscribe | Subscription Help | Contact Us

Did you get this as a forward? Sign up to receive Office on Women's Health updates.

Stay connected with us!

Womenshealth.gov
OWH Helpline: 800-994-9662 | womenshealth@hhs.gov

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: The Office on Women's Health (OWH) · 200 Independence Avenue · Washington, DC 20201 · 202-690-7650

Deadline Extended for OWH's Challenge Competitions!!

Apply Today!! $3.1 Million Total Cash Prizes to Advance Health Equity.

Having trouble viewing this email? View it as a Web page.

OWH Launches Two National Prize Competitions

The HHS Office on Women's Health (OWH) recently announced two national prize competitions. OWH will award $3.1 million in cash prizes for innovative methods designed to advance health equity.

HHS Racial Equity in Postpartum Care Challenge

OWH in partnership with the Centers for Medicare and Medicaid Services will award prizes for innovative methods designed to improve postpartum care for Black or African American and American Indian/Alaska Native women enrolled in Medicaid or the Children's Health Insurance Program (CHIP). The emphasis will be on follow-up care for diabetes, postpartum depression and/or postpartum anxiety, hypertension, and substance use disorders (SUD).

Deadline (Phase 1): February 28, 2022

CLICK HERE TO APPLY

Join the Postpartum Challenge Information Session!

We look forward to having you join us at one of the two sessions below to learn more about the challenge. Please share this information widely with your networks.

Webinar I: January 31, 2022 Time: 12:30 pm ET. Register

Webinar II: February 9, 2022 Time: 12:00 pm ET. Register

HHS Endocrine-Disrupting Chemicals (EDC) Innovator Award Competition

Endocrine-disrupting chemicals interfere with the body's hormones and may cause adverse health effects. This OWH competition is looking for programs that increase awareness of the risks associated with EDCs and provide solutions to reduce EDC exposure for Black or African American women.

Deadline (Phase I): March 31, 2022

CLICK HERE TO APPLY

NINR News and Notes Digest: January 2022

NINR's online newsletter, providing the latest nursing science discoveries, funding and training opportunities, and news.

Having trouble viewing this email? View it as a Web page.

News and Notes is NINR's online newsletter, providing the latest nursing science discoveries, funding and training opportunities, and news about our events and initiatives.

Funding Opportunities

RFA-NR-22-002 and RFA-NR-22-003: "Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes Among Women Who Experience Persistent Disparities" seek to foster intervention research that addresses structural inequities and reduces disparities in severe maternal morbidity and mortality.

RFA-NR-22-001: "Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)" aims to identify and evaluate the ongoing and long-term impacts of the COVID-19 pandemic, focusing specifically on governmental (local, state, tribal, federal) policy and programmatic actions that address two specific social determinants of health: food/nutrition security and housing security.

Job Opportunities

NINR is Hiring for Key Leadership Positions

NINR is seeking applications from outstanding candidates for:

1) Deputy Director, NINR

2) Director, Division of Extramural Science Programs (DESP)

3) Clinical Director, Division of Intramural Research (DIR)

4) Scientific Director, Division of Intramural Research (DIR)

The positions are part of the NINR senior leadership team and report directly to the NINR Director.

Events

2022 National Nursing Research Roundtable

Join the NINR and the Emergency Nurses Association (ENA) on March 3-4 for the 2022 National Nursing Research Roundtable (NNRR), titled "From Context to Care: Understanding the Convergence of Social Factors and Emergency Department Care." Read More

January 2022 Advisory Council Video Available

Video of the January 2022 public session of the National Advisory Council for Nursing Research is now available to view. Read More

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute of Nursing Research National Institutes of Health · 31 Center Drive, Room 5B10 · Bethesda, MD 20892-2178

COVID-19 News: NIAID Trial Tests Strategy to Augment Response to COVID-19 Vaccines in Transplant Recipients

Does temporarily reducing immunosuppressive medication safely allow for better antibody responses to vaccination?

Monday, January 31, 2022

NIAID Trial Tests Strategy to Augment Response to COVID-19 Vaccines in Transplant Recipients

SEM image of cell infected with SARS-CoV-2

Colorized scanning electron micrograph of a cell (purple) infected with a variant strain of SARS-CoV-2 virus particles (pink), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility in Fort Detrick, Maryland. Credit: NIAID

A new NIAID-funded clinical trial is testing whether temporarily reducing immunosuppressive medication taken during the days before and after an additional dose of an mRNA COVID-19 vaccine safely allows for better antibody responses to vaccination in kidney and liver transplant recipients. The study team is enrolling people for whom two to four doses of a COVID-19 mRNA vaccine did not elicit a detectable antibody response. The trial is called COVID Protection After Transplant‒Immunosuppression Reduction, or CPAT-ISR.

National Institute of Allergy and Infectious Diseases | National Institutes of Health

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help.

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107